PPH Legal Blog

Primary Pulmonary Hypertension (PPH) is a rare and life-threatening lung disease, which results in increased blood pressure in the lungs, creating additional stress on the heart and lungs.  Patients with the disease are often short of breath, dizzy, and lacking energy, because their bodies simply don’t get enough oxygen and are working under extreme pressure.  […]

[Read more →]

Teva Pharmaceutical Industries announced that the Federal Food and Drug Administration approved their new drug application for a generic pulmonary hypertension drug.   Teva’s drug, Epoprostenol, is a version of GlaxoSmithKline’s Flolan for Injection.  Although the drug will not cure pulmonary hypertension, it will help improve the symptoms and quality of life for patients.
During the last […]

[Read more →]

The lawyers who sued the makers of Fen-Phen on behalf of thousands of plaintiffs have been awarded $412 million for their efforts that spanned nearly a decade.  Federal Judge Harvey Bartle III of Philadelphia awarded the money for more than 578,000 hours of work.  The money is in addition to a $156 million settlement that […]

[Read more →]

A Massachusetts teenager, Cassie Tessier, is awaiting a double lung transplant that will save her life.  Tessier currently has a pill regiment four times a day, frequent blood transfusions, oxygen supplementation, and has a pump that helps move the medication more efficiently into her heart.
Tessier was diagnosed in 2000 with pulmonary hypertension, a rare and debilitating blood […]

[Read more →]

An Ohio woman, Carol Dickson, had struggled for years to catch her breath while moving about town.  Finally, after a hospitalization and near death experience, she was diagnosed with Pulmonary Hypertension.  Diseases like Pulmonary Hypertension adversely limits the body’s ability to distribute oxygen, making patients feel short of breath and dizzy, unwilling and unable to […]

[Read more →]